Current Cancer Therapy Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.8 | Q4 | 8.1% | 0.214 | Q4 | 30.5% |
| 2024 | 0.9 | Q4 | 12.0% | 0.206 | Q4 | 32.1% |
| 2023 | 0.4 | Q4 | 7.1% | 0.172 | Q4 | 29.7% |
| 2022 | 0.6 | 7.8% | 0.147 | Q4 | 27.9% | |
| 2021 | — | 25.2% | 0.117 | Q4 | 22.5% | |
| 2020 | — | — | 0.128 | Q4 | 14.8% | |
| 2019 | — | — | 0.128 | Q4 | 21.6% | |
| 2018 | — | — | 0.140 | Q4 | 18.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1573-3947
ISSN
1875-6301
country
AEcoverage
2006-2026